We are live on
!
Find out more
EOJOAM
E. Ohman J:or Asset Management Portfolio holdings
AUM
$4.3B
1-Year Est. Return
29.55%
This Fund
S&P 500
This Quarter
Est. Return
+6.12%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$1.13B
AUM Growth
+$133M
(+13%)
Cap. Flow
+$76.8M
Cap. Flow
% of AUM
6.83%
Top 10 Holdings %
Top 10 Hldgs %
29.98%
Holding
565
New
6
Increased
343
Reduced
14
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$11.6M |
| 2 |
ICICI Bank
IBN
|
+$6.87M |
| 3 |
Verizon
VZ
|
+$6.14M |
| 4 |
Palo Alto Networks
PANW
|
+$6.09M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$4.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$5.32M |
| 2 |
AABA
Altaba Inc
AABA
|
+$4.73M |
| 3 |
MacroGenics
MGNX
|
+$3.45M |
| 4 |
Bank of America
BAC
|
+$2.88M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$2.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 18.55% |
| 3 | Consumer Discretionary | 14.98% |
| 4 | Communication Services | 14.5% |
| 5 | Healthcare | 14.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Fortune Brands Innovations
FBIN
$5.73B
| $229K | 0.02% |
3,978
| – | – |
|
427
Vail Resorts
MTN
$5.21B
| $228K | 0.02% |
1,000
| – | – |
|
428
Steel Dynamics
STLD
$38.5B
| $228K | 0.02% |
6,600
| – | – |
|
429
East-West Bancorp
EWBC
$18.1B
| $227K | 0.02% |
3,800
| – | – |
|
430
Avery Dennison
AVY
$13.5B
| $226K | 0.02% |
2,300
+200
| +10% | +$18.8K |
|
431
Jack Henry & Associates
JKHY
$11B
| $226K | 0.02% |
2,200
| – | – |
|
432
DaVita
DVA
$11.7B
| $226K | 0.02% |
3,800
+300
| +9% | +$18.1K |
|
433
Howmet Aerospace
HWM
$113B
| $226K | 0.02% |
11,822
+956
| +9% | +$18.3K |
|
434
Leidos
LDOS
$17.5B
| $225K | 0.02% |
3,800
| – | – |
|
435
Nasdaq
NDAQ
$53.4B
| $225K | 0.02% |
8,700
| – | – |
|
436
Kohl's
KSS
$2.16B
| $224K | 0.02% |
4,900
| – | – |
|
437
FMC
FMC
$1.31B
| $223K | 0.02% |
2,883
| – | – |
|
438
MSCI
MSCI
$40.9B
| $222K | 0.02% |
1,900
+100
| +6% | +$11.1K |
|
439
Crown Holdings
CCK
$13.1B
| $221K | 0.02% |
3,700
+200
| +6% | +$11.9K |
|
440
Alliant Energy
LNT
$17.7B
| $220K | 0.02% |
5,300
+300
| +6% | +$12.5K |
|
|
HBI
441
DELISTED
Hanesbrands
HBI
| $219K | 0.02% |
8,900
+500
| +6% | +$12K |
|
442
UDR
UDR
$12.1B
| $217K | 0.02% |
5,700
+400
| +8% | +$15.5K |
|
|
FDC
443
DELISTED
First Data Corporation
FDC
| $215K | 0.02% |
11,900
| – | – |
|
444
Harley-Davidson
HOG
$2.72B
| $212K | 0.02% |
4,400
| – | – |
|
445
Hormel Foods
HRL
$13.6B
| $212K | 0.02% |
6,600
+200
| +3% | +$6.54K |
|
446
Federal Realty Investment Trust
FRT
$10.2B
| $211K | 0.02% |
1,700
+100
| +6% | +$12.9K |
|
447
Regency Centers
REG
$13.9B
| $211K | 0.02% |
3,400
+200
| +6% | +$12.9K |
|
|
CIT
448
DELISTED
CIT Group Inc.
CIT
| $211K | 0.02% |
4,300
+300
| +8% | +$14.1K |
|
449
Macy's
M
$6.55B
| $209K | 0.02% |
9,600
| – | – |
|
450
Reinsurance Group of America
RGA
$15.8B
| $209K | 0.02% |
1,500
+100
| +7% | +$13.5K |
|
Similar funds
IWM
CW
IUHSA
MYIA
NEI
CIC
SLI
E. Ohman J:or Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, E. Ohman J:or Asset Management held 565 positions worth $1.13B, up 13% from $992M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
E. Ohman J:or Asset Management deployed $76.8M of net new capital in Q3 2017, opening 6 new positions and adding to 343 existing holdings. Its largest new stake was Teva Pharmaceuticals: 206,483 shares worth $3.63M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Hologic, an estimated $5.32M trimmed.
- E. Ohman J:or Asset Management's largest Q3 2017 buy was Teva Pharmaceuticals: 206,483 shares worth $3.63M.
- E. Ohman J:or Asset Management added most to Eli Lilly in Q3 2017, an estimated $11.6M increase.
- E. Ohman J:or Asset Management's biggest Q3 2017 reduction was Hologic, cutting an estimated $5.32M.
- E. Ohman J:or Asset Management fully exited MacroGenics in Q3 2017, selling an estimated $3.45M.
- E. Ohman J:or Asset Management's ten largest holdings make up 30% of its $1.13B portfolio in Q3 2017.
- E. Ohman J:or Asset Management opened 6 new positions and closed 6 in Q3 2017.
- E. Ohman J:or Asset Management's portfolio value rose 13% quarter-over-quarter to $1.13B.
Based on E. Ohman J:or Asset Management's 13F filing for Q3 2017, filed 5 Apr 2024.